Form D · Biotechnology
NUMERATE INC
San Bruno, CA · CIK 0001439005
Offering snapshot reported Jun 4, 2014 · SEC filing
- Reported sold
- $8.24M Offering amount: $9.24M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 23, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 4, 2014 | Initial | $8,240,487 | No comparison | 5 | SEC filing |
| Mar 2, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 27, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-218564
Source: Form D, filed Jun 4, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bruce Booth | Director |
| John Griffin | Executive |
| Steve Hall | Director |
| Guido Lanza | Director, Executive |
| Lucio Lanza | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1150 Bayhill Drive Suite 203
San Bruno, CA, 94066
San Bruno, CA, 94066